Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Arlene Helen Sharpe, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Arlene Sharpe and Brian Miller.
Connection Strength

0.962
  1. Prevention of CAR-T-cell dysfunction. Nat Biomed Eng. 2020 01; 4(1):16-17.
    View in: PubMed
    Score: 0.219
  2. Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019 Nov; 20(11):1556.
    View in: PubMed
    Score: 0.217
  3. PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity. Nat Immunol. 2019 10; 20(10):1335-1347.
    View in: PubMed
    Score: 0.215
  4. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019 03; 20(3):326-336.
    View in: PubMed
    Score: 0.206
  5. Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity. Cell. 2020 12 23; 183(7):1848-1866.e26.
    View in: PubMed
    Score: 0.058
  6. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature. 2017 07 27; 547(7664):413-418.
    View in: PubMed
    Score: 0.046
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.